Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: Seeking confirmation of the association in a follow-up study

Pharmacogenetics

Volumn 12, Issue 7, 2002, Pages 585-587

  Johnstone, Elaine C ^a   Clark, Taane G ^a   Griffiths, Siân Elin ^a   Murphy, Michael F G ^a   Walton, Robert T ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Catechol O methyl transferase; DRD2; Monoamine oxidase A; Smoking; Tobacco consumption

Indexed keywords

DOPAMINE; DOPAMINE BETA MONOOXYGENASE; NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING HABIT; TOBACCO;

COHORT STUDIES; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SMOKING; TOBACCO USE DISORDER;

NICOTIANA TABACUM;

EID: 0036799158     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200210000-00012     Document Type: Article

References (11)

1. Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 2000; 32:1-112.
2. Corrigall WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 1992; 107:285-289.
3. Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, et al. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 2000; 5:56-63.
4. Shih JC, Thompson RF. Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 1999; 65:593-598.
5. Berlin I, Anthenelli RM. Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 2001; 4:33-42.
6. McKinney EF, Walton RT, Yudkin P, Fuller A, Haldar NA, Mant D, et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 2000; 10:483-491.
7. Imperial Cancer Research Fund Oxcheck Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the Oxcheck study. BMJ 1995; 310:1099-1104.
8. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001; 68:515-522.
9. Hastie T, Tibshirani R. Generalised additive models. London: Chapman & Hall; 1990.
10. Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne K, et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14 000 cases and 32 000 controls in the United Kingdom. The international studies of infarct survival (ISIS) collaborators. BMJ 1995; 311:471-477.
11. Yang M, Kunugita N, Kitagawa K, Kang SH, Coles B, Kadlubar FF, et al. Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes. Cancer Epidemiol Biomarkers Prev 2001; 10:589-593.